JPRN-UMIN000021356已完成未知
The effecs of intensive lipid-lowering therapy on the progression of atherosclerotic kidney disease - Lipid-lowering therapy for CKD
niversity, School of Medicine0 个研究点目标入组 40 人开始时间: 2016年3月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with diabetes
研究者
相似试验
已完成
不适用
Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound StudyAcute Coronary SyndromeJPRN-UMIN000003620Hyogo College of Medicine Cardiovascular Division50
尚未招募
不适用
Influence of a Lipoprotein(a)-Lowering Therapy on Insulin SensitivityE78.5Hyperlipidaemia, unspecifiedDRKS00031748Charité Universitätsmedizin Berlin13
招募中
Unknown
Impact of Aggressive Lipid-Lowering Therapy with Evolocumab on Peripheral Atherosclerotic Plaque Assessed with NIRS-IVUS in Patients with Peripheral Artery DiseasePeripheral artery diseaseJPRN-UMIN000049231niversity of Fukui Division of Cardiovascular Medicine, Faculty of Medical Sciences30
进行中（未招募）
不适用
The effect of intensive lipid lowering on markers of inflammation in patients with stable coronary artery disease. - Intensive lipid loweringPatients with cardiovascular risk factors and stable coronary artery disease, with a fasting total cholesterol level =5 mmol/l.EUCTR2005-005084-29-GBChief Scientitst Office
已完成
不适用
Effect of prolonged cholesterol lowering treatment on trained immunity of monocytes in patients with elevated levels of LDL-cholesterolCardiovascular diseasehypercholesterolemiaNL-OMON49515Radboud Universitair Medisch Centrum30